Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer
MCA Wouters, BH Nelson - Clinical Cancer Research, 2018 - AACR
There is abundant evidence that tumor-infiltrating CD8+ T cells contribute positively to
antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …
antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
D Ostroumov, N Fekete-Drimusz, M Saborowski… - Cellular and molecular …, 2018 - Springer
The outstanding clinical success of immune checkpoint blockade has revived the interest in
underlying mechanisms of the immune system that are capable of eliminating tumors even …
underlying mechanisms of the immune system that are capable of eliminating tumors even …
Glypican‐3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment
Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular
carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently …
carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently …
Treatment of liver cancer
CY Liu, KF Chen, PJ Chen - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer.
Incidence of liver cancer varies geographically and parallels with the geographic prevalence …
Incidence of liver cancer varies geographically and parallels with the geographic prevalence …
Neoantigen targeting—dawn of a new era in cancer immunotherapy?
TC Wirth, F Kühnel - Frontiers in immunology, 2017 - frontiersin.org
During their development and progression tumors acquire numerous mutations that, when
translated into proteins give rise to neoantigens that can be recognized by T cells. Initially …
translated into proteins give rise to neoantigens that can be recognized by T cells. Initially …
Cell surface sphingomyelin: Key role in cancer initiation, progression, and immune evasion
Cell surface biochemical changes, notably excessive increase in outer leaflet sphingomyelin
(SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable …
(SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable …
[HTML][HTML] Immunotherapy in hepatocellular carcinoma
L Buonaguro, A Mauriello, B Cavalluzzo, A Petrizzo… - Annals of hepatology, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is considered an immunogenic tumor that arises in
chronically inflamed livers due to underlying chronic liver disease caused by viral and non …
chronically inflamed livers due to underlying chronic liver disease caused by viral and non …
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls
Background Circulating biomarkers are urgently needed in hepatocellular carcinoma (HCC).
The aims of this study were to determine the feasibility of detecting and isolating circulating …
The aims of this study were to determine the feasibility of detecting and isolating circulating …
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis
J Zhang, M Zhang, H Ma, X Song, L He, X Ye, X Li - Medicine, 2018 - journals.lww.com
Background: Glypican-3 (GPC3) has been widely recognized in the progression of liver
tumors for several years. The relationship between overexpression of GPC3 and the poorer …
tumors for several years. The relationship between overexpression of GPC3 and the poorer …
Clearance of circulating tumor cells in patients with hepatocellular carcinoma undergoing surgical resection or liver transplantation
V Amado, S González-Rubio, J Zamora, R Alejandre… - Cancers, 2021 - mdpi.com
Simple Summary Liver transplantation and surgical resection are potentially curative options
in patients with liver cirrhosis and hepatocellular carcinoma. However, tumor recurrence is …
in patients with liver cirrhosis and hepatocellular carcinoma. However, tumor recurrence is …